Accès à distance ? S'identifier sur le proxy UCLouvain
DUSP4 expression level in colorectal primaries predicts overall survival benefit in Kras wild-type and Kras mutant colorectal cancer after treatment with cetuximab for metastatic disease
Primary tabs
- Open access
- 60.29 K
| Document type | Communication à un colloque (Conference Paper) – Poster |
|---|---|
| Access type | Accès libre |
| Publication date | 2008 |
| Language | Anglais |
| Conference | "20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics", (Switzerland) Geneva (du 24/10/2008 au 28/10/2008) |
| Journal information | "EJC - Supplements" - Vol. 6, no. 12, p. 33 (2008) |
| Peer reviewed | yes |
| issn | 1359-6349 |
| Publisher | Pergamon ((United Kingdom) Oxford) |
| Publication status | Publié |
| Affiliations |
UCL
- MD/MINT - Département de médecine interne UCL - (SLuc) Unité d'oncologie médicale |
| Links |
| Bibliographic reference | De Roock, Wendy ; Janssens, Marc ; Biesmans, Bart ; Jacobs, Bart ; De Schutter, Jef ; et. al. DUSP4 expression level in colorectal primaries predicts overall survival benefit in Kras wild-type and Kras mutant colorectal cancer after treatment with cetuximab for metastatic disease.20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics ((Switzerland) Geneva, du 24/10/2008 au 28/10/2008). In: EJC - Supplements, Vol. 6, no. 12, p. 33 (2008) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/59065 |